Patients with GDF-15 concentrations above the median were older, had longer diabetes duration, lower eGFR and LDL cholesterol and were more frequently treated with oral antidiabetic drugs than patients with GDF-15 concentrations below the median. The gene discussed is GDF15; the disease is diabetes mellitus.